• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初治患者中与慢性丙型肝炎病毒感染相关的严重肝病:2000年至2007年及2010年至2014年法国首个专家中心就诊时的流行病学特征及相关因素

Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.

作者信息

Sanna Alice, Le Strat Yann, Roudot-Thoraval Françoise, Deuffic Burban Sylvie, Carrieri Patrizia, Delarocque-Astagneau Elisabeth, Larsen Christine

机构信息

Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Paris, France.

出版信息

Euro Surveill. 2017 Jul 27;22(30). doi: 10.2807/1560-7917.ES.2017.22.30.30582.

DOI:10.2807/1560-7917.ES.2017.22.30.30582
PMID:28797326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553056/
Abstract

Given recent profound improvements in the effectiveness of antiviral treatment for chronic Hepatitis C virus (HCV) infection, we aimed to describe the characteristics of patients referred to hepatology expert centres in France from 2000 to 2007 and from 2010 to 2014, and to identify factors associated with severe liver disease at their first visit for evaluation. We analysed data from two sources covering all of France: the former hepatitis C surveillance network, which included patients between 2000 and 2007, and the ANRS CO22 HEPATHER multi-centre cohort, which included patients between 2012 and 2014. Severe liver disease (SLD) was defined as the presence of either cirrhosis (histological, biochemical or clinical) or hepatocellular carcinoma. Multivariable Poisson regression models were used to identify the factors associated with SLD in complete-case analysis and after multiple imputation. Overall, 16,851 patients were included in the analysis and SLD was diagnosed in 11.6%. SLD at first visit was significantly associated with known risk factors (male sex, history of excessive alcohol intake, HCV genotype 3), late referral to hepatologists after diagnosis and HCV diagnosis at an older age. Providing earlier specialised care and treatment may be an important target for public health action.

摘要

鉴于近期慢性丙型肝炎病毒(HCV)感染抗病毒治疗效果有了显著改善,我们旨在描述2000年至2007年以及2010年至2014年转诊至法国肝病专家中心的患者特征,并确定其首次就诊评估时与严重肝病相关的因素。我们分析了来自法国全境的两个数据源的数据:前丙型肝炎监测网络,涵盖2000年至2007年的患者;以及ANRS CO22 HEPATHER多中心队列,涵盖2012年至2014年的患者。严重肝病(SLD)定义为存在肝硬化(组织学、生化或临床诊断)或肝细胞癌。多变量泊松回归模型用于在完全病例分析和多次插补后确定与严重肝病相关的因素。总体而言,16,851名患者纳入分析,其中11.6%被诊断为严重肝病。首次就诊时的严重肝病与已知危险因素(男性、过量饮酒史、HCV基因3型)、诊断后转诊至肝病专家较晚以及年龄较大时诊断出HCV显著相关。提供更早的专科护理和治疗可能是公共卫生行动的一个重要目标。

相似文献

1
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.初治患者中与慢性丙型肝炎病毒感染相关的严重肝病:2000年至2007年及2010年至2014年法国首个专家中心就诊时的流行病学特征及相关因素
Euro Surveill. 2017 Jul 27;22(30). doi: 10.2807/1560-7917.ES.2017.22.30.30582.
2
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.在法国一个大型吸毒者人群中,丙型肝炎病毒基因型 3 与严重肝病的风险。
J Med Virol. 2010 Oct;82(10):1647-54. doi: 10.1002/jmv.21850.
3
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.直接作用抗病毒治疗后慢性丙型肝炎患者的临床结局:一项前瞻性队列研究。
Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.
4
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第1部分:重症丙型肝炎和注射者数据。
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
5
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.法国慢性感染轻度肝纤维化患者中丙型肝炎病毒亚型分布:GEMHEP 研究。
Epidemiol Infect. 2019 Jan;147:e234. doi: 10.1017/S0950268819001225.
6
SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.SEN病毒感染影响肝脏的病理表现,但不影响慢性丙型肝炎和肝硬化患者肝细胞癌的发病率。
Liver Int. 2005 Apr;25(2):226-35. doi: 10.1111/j.1478-3231.2005.01076.x.
7
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.丙型肝炎病毒4型感染的流行病学特征及对聚乙二醇干扰素联合利巴韦林治疗的反应
J Viral Hepat. 2007 Jul;14(7):460-7. doi: 10.1111/j.1365-2893.2006.00823.x.
8
Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study.韩国丙型肝炎病毒感染的临床和流行病学特征:一项前瞻性、多中心队列研究。
J Med Virol. 2013 Oct;85(10):1724-33. doi: 10.1002/jmv.23661. Epub 2013 Jun 28.
9
Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.慢性丙型肝炎队列研究(CHeCS)中丙型肝炎患者的肝硬化患病率:一项回顾性和前瞻性观察研究。
Am J Gastroenterol. 2015 Aug;110(8):1169-77; quiz 1178. doi: 10.1038/ajg.2015.203. Epub 2015 Jul 28.
10
The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.希腊转诊三级中心主要慢性肝病的负担和近期流行病学变化。
Eur J Gastroenterol Hepatol. 2010 Feb;22(2):172-9. doi: 10.1097/MEG.0b013e328331115b.

引用本文的文献

1
Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER).慢性乙型肝炎病毒感染的移民和非移民个体的死亡风险:一项基于法国医院的队列研究(ANRS CO22 HEPATHER)
BMC Glob Public Health. 2025 Jul 1;3(1):58. doi: 10.1186/s44263-025-00173-7.
2
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019.2019 年,在三个欧洲国家的临床中心建立了一个哨点监测系统,以监测慢性乙型和丙型肝炎感染的治疗和治疗结果。
Euro Surveill. 2023 Feb;28(6). doi: 10.2807/1560-7917.ES.2023.28.6.2200184.
3
The Role of Bcl-xL Protein in Viral Infections.Bcl-xL 蛋白在病毒感染中的作用。
Int J Mol Sci. 2021 Feb 16;22(4):1956. doi: 10.3390/ijms22041956.
4
Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern Brazil.巴西北部帕拉州丙型肝炎病毒基因型及相关危险因素分析。
Braz J Infect Dis. 2020 Jul-Aug;24(4):304-309. doi: 10.1016/j.bjid.2020.06.010. Epub 2020 Jul 28.
5
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.意大利 2001 年和 2014 年两个队列中慢性肝病的性别差异。
Infection. 2018 Feb;46(1):93-101. doi: 10.1007/s15010-017-1101-5. Epub 2017 Nov 17.

本文引用的文献

1
EASL Recommendations on Treatment of Hepatitis C 2016.2016年欧洲肝脏研究学会丙型肝炎治疗指南
J Hepatol. 2017 Jan;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001. Epub 2016 Sep 22.
2
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.达卡他韦联合索非布韦治疗 HCV 基因 1 型单感染患者的安全性和疗效。
J Hepatol. 2017 Jan;66(1):39-47. doi: 10.1016/j.jhep.2016.08.021. Epub 2016 Sep 10.
3
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.2014 年法国乙型肝炎和丙型肝炎筛查指南:一种针对慢性病毒(即 HBV、HCV 和 HIV)的靶向和大规模联合检测策略。
Liver Int. 2016 Oct;36(10):1442-9. doi: 10.1111/liv.13135. Epub 2016 May 1.
4
Advances in hepatitis C therapy: What is the current state - what come's next?丙型肝炎治疗的进展:现状如何——接下来会怎样?
World J Hepatol. 2016 Jan 28;8(3):139-47. doi: 10.4254/wjh.v8.i3.139.
5
Disease burden of chronic hepatitis C among immigrants in Canada.加拿大移民中丙型肝炎的疾病负担。
J Viral Hepat. 2015 Dec;22(12):1043-54. doi: 10.1111/jvh.12432. Epub 2015 Jun 25.
6
Combining fractional polynomial model building with multiple imputation.将分数多项式模型构建与多重填补相结合。
Stat Med. 2015 Nov 10;34(25):3298-317. doi: 10.1002/sim.6553. Epub 2015 Jun 10.
7
Immigration and viral hepatitis.移民与病毒性肝炎。
J Hepatol. 2015 Aug;63(2):515-22. doi: 10.1016/j.jhep.2015.04.026. Epub 2015 May 8.
8
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.法国未被诊断出的慢性丙型肝炎病毒感染人群。对2014年扩大检测建议的影响。
PLoS One. 2015 May 11;10(5):e0126920. doi: 10.1371/journal.pone.0126920. eCollection 2015.
9
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.欧洲肝脏研究学会-阿莱赫临床实践指南:用于评估肝脏疾病严重程度和预后的非侵入性检查
J Hepatol. 2015 Jul;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006. Epub 2015 Apr 21.
10
Natural history of hepatitis C.丙型肝炎的自然史。
J Hepatol. 2014 Nov;61(1 Suppl):S58-68. doi: 10.1016/j.jhep.2014.07.012. Epub 2014 Nov 3.